Myocardial Infarction News and Research

RSS

Insomnia common in heart disease patients and linked with subsequent cardiovascular events

Nearly half of heart disease patients have insomnia, according to research presented at ESC Preventive Cardiology 2022, a scientific congress of the European Society of Cardiology, and published in SLEEP Advances.

7 Apr 2022

Sodium thiosulfate shows no benefits for reducing heart damage following a heart attack

Sodium thiosulfate showed no benefits for reducing injury to damaged areas of heart muscle following a heart attack, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

5 Apr 2022

Implantable heart rhythm monitor does not benefit NSTEMI patients

Patients who received an implantable heart rhythm monitor after suffering a heart attack did not have fewer subsequent cardiovascular events overall, but a subset of patients whose heart attack was classified as non-ST segment elevation myocardial infarction (NSTEMI) did see strong benefits, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

5 Apr 2022

Study generates a picture of the myocardial transcriptional landscape of COVID-19

Researchers profiled cardiac tissue transcriptomes of COVID-19 patients.

5 Apr 2022

Higher cereal fiber intake associated with lower inflammation

A new study assesses the association between dietary fiber intake with inflammatory markers associated with cardiovascular disease.

4 Apr 2022

Addition of alirocumab to high-intensity statin treatment reduces key measures of plaque vulnerability

Compared with a placebo, the addition of the injectable cholesterol-lowering drug alirocumab to high-intensity statin treatment in patients who have had a heart attack resulted in twofold greater reductions in three key measures of plaque vulnerability that signal risk for future cardiac events, according to research presented at the American College of Cardiology's 71st Annual Scientific Session.

3 Apr 2022

Investigational drug vupanorsen reduces non-HDL cholesterol by up to 28%

The investigational drug vupanorsen reduced total levels of non-high-density lipoprotein (non-HDL) cholesterol by up to 28% in patients with high cholesterol who were already taking a cholesterol-lowering statin medication, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

3 Apr 2022

Smokers have lower odds of surviving a heart attack than non-smokers

Smokers have a lower chance of surviving a heart attack than non-smokers, according to new data compiled by researchers at Jordan University of Science and Technology in Irbid.

2 Apr 2022

Clinical algorithm distinguishes between untreatable and treatable form of sudden cardiac arrest

Clinician-scientists in the Smidt Heart Institute at Cedars-Sinai developed a clinical algorithm that, for the first time, distinguishes between treatable sudden cardiac arrest and untreatable forms of the condition.

31 Mar 2022

The potential risk of SARS-CoV-2 transmission through fomites contaminated by hospitalized COVID-19 patients

Researchers evaluated the potential risk of SARS-CoV-2 transmission through fomites contaminated by hospitalized COVID-19 patients during coughing or intense moistening with saliva.

28 Mar 2022

Study finds fewer hospital visits for stroke in first year of COVID-19 pandemic

The first year of the COVID-19 pandemic saw fewer hospital visits for stroke, fewer stroke therapies, more treatment delays and a higher risk of in-hospital deaths in the subsequent COVID-19 waves, according to an Alberta study published in CMAJ.

28 Mar 2022

Programmable button technology reduces the time for heart attack diagnosis

Shaving critical minutes off the time it takes to diagnose a heart attack and begin treatment could be as simple as the push of a button.

24 Mar 2022

Heart attack survivors with depression more likely to suffer a stroke

Depression can complicate and slow recovery from a heart attack, not to mention the toll it can take on one's mental outlook, relationships and joy of life.

23 Mar 2022

Study finds high rate of cognitive impairment after heart attack

A heart attack's impact on the brain may be more serious than previously understood. About 1 in 3 heart attack survivors showed significant mental decline in the days and months following their heart attack, according to a study presented at the American College of Cardiology's 71st Annual Scientific Session.

23 Mar 2022

People living in noisy environment more likely to suffer a heart attack

Living in a noisy environment can be annoying, but it might also harm your health. People experiencing high levels of noise from cars, trains or planes were more likely to suffer a heart attack than people living in quieter areas, according to a study presented at the American College of Cardiology's 71st Annual Scientific Session.

23 Mar 2022

Men with periodontitis and erectile dysfunction more likely to suffer major adverse cardiovascular event

A team of researchers led by the University of Granada has shown in a prospective study that men with periodontitis who are also diagnosed with erectile dysfunction are almost four times more likely to suffer a major adverse cardiovascular event (MACE).

22 Mar 2022

Dyspnea or fatigue can lead to worse outcomes than chest pain for heart attack patients

Just 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one year compared to 94% of those with chest pain as the predominant feature.

19 Mar 2022

Women less likely to receive lifesaving intervention for cardiogenic shock than men

Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology.

19 Mar 2022

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

A team of scientists from Iran has recently estimated the prevalence of coronavirus disease 2019 (COVID-19) in myocardial infarction patients receiving a primary percutaneous coronary intervention. A considerably high prevalence of COVID-19 has been observed among study participants. The study is currently available on the Research Square* Preprint Server.

16 Mar 2022

Spray-on technology using customized gold nanoparticles could help treat heart disease

Could a spritz of super-tiny particles of gold and peptides on a damaged heart potentially provide minimally invasive, on-the-spot repair?

15 Mar 2022

Myocardial Infarction News and Research

Insomnia common in heart disease patients and linked with subsequent cardiovascular events

Sodium thiosulfate shows no benefits for reducing heart damage following a heart attack

Implantable heart rhythm monitor does not benefit NSTEMI patients

Study generates a picture of the myocardial transcriptional landscape of COVID-19

Higher cereal fiber intake associated with lower inflammation

Addition of alirocumab to high-intensity statin treatment reduces key measures of plaque vulnerability

Investigational drug vupanorsen reduces non-HDL cholesterol by up to 28%

Smokers have lower odds of surviving a heart attack than non-smokers

Clinical algorithm distinguishes between untreatable and treatable form of sudden cardiac arrest

The potential risk of SARS-CoV-2 transmission through fomites contaminated by hospitalized COVID-19 patients

Study finds fewer hospital visits for stroke in first year of COVID-19 pandemic

Programmable button technology reduces the time for heart attack diagnosis

Heart attack survivors with depression more likely to suffer a stroke

Study finds high rate of cognitive impairment after heart attack

People living in noisy environment more likely to suffer a heart attack

Men with periodontitis and erectile dysfunction more likely to suffer major adverse cardiovascular event

Dyspnea or fatigue can lead to worse outcomes than chest pain for heart attack patients

Women less likely to receive lifesaving intervention for cardiogenic shock than men

High prevalence of COVID-19 in myocardial infarction patients undergoing percutaneous coronary intervention

Spray-on technology using customized gold nanoparticles could help treat heart disease

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News